The Latest Breaking News from McKesson

With McKesson gearing up to release its first-quarter earnings next month, analysts project a single-digit earnings dip.

McKesson (MCK) reported consistent revenue growth and solid profit margins in the last reported quarter, supported by robust demand for pharmaceuticals and medical supplies and efficient cost management. With nearly 25% year-to-date gains, should you invest in this healthcare stock? Read on to learn more….

Whistleblower lawsuit against McKesson revived over alleged illegal kickback schemes. Importance of transparency in healthcare industry highlighted.

Are you looking for probiotics to boost your emotional well-being? Explore our curated list of the top 13 mood probiotics known for enhancing digestion and promoting brain health.

Given the growing demand for healthcare facilities, rapid integration of digital technology, and transformative biotechnology breakthroughs, the medical industry is poised for continued growth and profitability this year and beyond. Amid this, let’s find out why investors are flocking to medical stocks Vertex Pharmaceuticals (VRTX) and McKesson (MCK). Read more….

Disney jumped before the open on earnings as AI play ARM surged. The S&P 500 is just below 5,000, but it's a "lockout" rally again.

Unlock the gates of wellness with these breakout healthcare stocks.

The major indexes confirmed the new stock market rally, fueled by tumbling Treasury yields. Arista Networks and Palantir were earnings winners.

Techs led futures higher, with Palantir and Roku among the big earnings winners. Fed chief Jerome Powell signaled no more rate hikes, fueling Wednesday's strong market rally.